SEC Form 4 · accession 0000899243-18-016654
Eledon Pharmaceuticals, Inc. · ELDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary A Lyons
Director
Period of report
Jun 13, 2018
Accepted (ET)
Jun 14, 2018 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404281
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.18 | Jun 13, 2018 | A | 9,100 | A | Jun 13, 2019 | Jun 13, 2028 | Common Stock | 9,100 | 9,100 | D |